drugset / Trial / NCT00440661

Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis

NCT00440661

Phase 4 Completed 96 enrolled Laboratoires NEGMA
RandomizedParallel-groupDouble-blindTreatment

Summary

Some inflammation mediators, notably IL-1, are implied in the joint degeneration phenomena of osteoarthritis. The aim of this study is to confirm in vivo the favourable effect of diacerhein on IL-1 and also to appreciate its effect on other synovial inflammation mediators.

Timeline

Start
2007-03
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Diacerein Small molecule

Indications